ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201
Changelian, Paul, Xu, Canxin, Mnich, Steve, Hope, Heidi, Kostecki, Kourtney, Hirsch, Jeff, Loh, Chin-Yi, Anderson, David, Blinn, James, Hockerman, Susan, Dick, Evan, Smith, Walter, Monahan, Joseph, Raoof, Tooraj, Forman, Seth, Burt, David, Barnes, Brad, Gordon, David, Walker, Neal, Sudzina, John, Tucker, Stephen, Jacobsen, Jon
Published in JID innovations (01.03.2024)
Published in JID innovations (01.03.2024)
Get full text
Journal Article